alexa Pharmacovigilance in the New Millennium: Challenges, Opportunities and New Directions

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Pharmacovigilance in the New Millennium: Challenges, Opportunities and New Directions

It is both a challenge and opportunity to write the first Editorin- Chief’s editorial for a new born journal. The main challenge is to convince the readership that bringing yet another journal in a world already overwhelmed by information overload is justified. Additional challenges include setting up the journal agenda and goals, mindful of the fact that our vision will define the personality and character of our journal. Why bring a new journal in a world where the journal population is exponentially expanding? This is a question that any first Editor-in- Chief needs to contemplate. In essence this question is no different than the question aspiring parents contemplate before deciding on having a baby: Why bring a new child in a world where the population is exponentially increasing? Quite often deciding to have a baby is a symbol of hope – the hope that that one baby will help make the world a better place.

Citation: Preda A (2013) Pharmacovigilance in the New Millennium: Challenges, Opportunities and New Directions. J Pharmacovigilance 1:e106.

 
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
 
adwords